Which of the following inhalational agent is contraindicated in renal disease?
**Core Concept**
The question tests the student's knowledge of **inhalational anesthetics** and their **contraindications**, specifically in the context of **renal disease**. This requires understanding of how different anesthetics are metabolized and eliminated from the body.
**Why the Correct Answer is Right**
The correct answer, **Methoxyflurane**, is contraindicated in renal disease because it is metabolized to **inorganic fluoride**, which can cause **nephrotoxicity**, especially in patients with pre-existing renal impairment. This is due to the high levels of fluoride ions that can damage renal tubules.
**Why Each Wrong Option is Incorrect**
**Option A:** Isoflurane is not contraindicated in renal disease as it produces minimal amounts of fluoride ions.
**Option B:** Sevoflurane, although metabolized to fluoride, is considered safe in renal disease due to its low metabolism rate.
**Option D:** Halothane is not specifically contraindicated in renal disease based on its metabolism.
**Clinical Pearl / High-Yield Fact**
It's crucial to remember that **Methoxyflurane** is uniquely problematic in renal disease due to its significant production of **inorganic fluoride**, making it a critical point for anesthesia management in patients with kidney issues.
**Correct Answer:** D. Methoxyflurane.